Summary

Fungal Keratitis Treatment Trends and Forecast
The future of the global fungal keratitis treatment market looks promising with opportunities in the hospital and drug store markets. The global fungal keratitis treatment market is expected to reach an estimated $589.6 million by 2030 with a CAGR of 5.7% from 2024 to 2030. The major drivers for this market are growing research activities to develop novel therapeutics, increasing sales volume of ophthalmic drugs for fungal keratitis disorders, along with the growing knowledge of the possible dangers associated with fungal keratitis and developments in its treatment.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Fungal Keratitis Treatment by Segment

The study includes a forecast for the global fungal keratitis treatment by route of administration, distribution channel, and region.

Fungal Keratitis Treatment Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:
• Oral
• Injection
• Topical








Fungal Keratitis Treatment Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals
• Drug Stores
• Others
































Fungal Keratitis Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Fungal Keratitis Treatment Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies fungal keratitis treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the fungal keratitis treatment companies profiled in this report include-
• Merck & Co
• Bausch Health
• Gilead Biosciences
• Pfizer
• Glenmark Pharmaceuticals







Fungal Keratitis Treatment Market Insights

Lucintel forecasts that topical will remain the largest segment over the forecast period.
Within this market, hospitals will remain the largest segment because of the aging population and rising rates of eye conditions, such as fungal keratitis, are driving up demand for hospital-based ophthalmic diagnostic services.

North America will remain the largest region over the forecast period due to growing cases of fungal keratitis and emerging trends in the treatment of fungal keratitis in the region.
Features of the Global Fungal Keratitis Treatment Market
Market Size Estimates: Fungal keratitis treatment market size estimation in terms of value ($M).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Fungal keratitis treatment market size by route of administration, distribution channel, and region in terms of value ($M).
Regional Analysis: Fungal keratitis treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different route of administration, distribution channel, and regions for the fungal keratitis treatment market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the fungal keratitis treatment market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ
Q1. What is the fungal keratitis treatment market size?
Answer: The global fungal keratitis treatment market is expected to reach an estimated $589.6 million by 2030.
Q2. What is the growth forecast for fungal keratitis treatment market?
Answer: The global fungal keratitis treatment market is expected to grow with a CAGR of 5.7% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the fungal keratitis treatment market?
Answer: The major drivers for this market are growing research activities to develop novel therapeutics, increasing sales volume of ophthalmic drugs for fungal keratitis disorders, along with the growing knowledge of the possible dangers associated with fungal keratitis and developments in its treatment.
Q4. What are the major segments for fungal keratitis treatment market?
Answer: The future of the global fungal keratitis treatment market looks promising with opportunities in the hospital and drug store markets.
Q5. Who are the key fungal keratitis treatment market companies?
Answer: Some of the key fungal keratitis treatment companies are as follows:
• Merck & Co
• Bausch Health
• Gilead Biosciences
• Pfizer
• Glenmark Pharmaceuticals





Q6. Which fungal keratitis treatment market segment will be the largest in future?
Answer: Lucintel forecasts that topical will remain the largest segment over the forecast period.
Q7. In fungal keratitis treatment market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to growing cases of fungal keratitis and emerging trends in the treatment of fungal keratitis in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the fungal keratitis treatment market by route of administration (oral, injection, and topical), distribution channel (hospitals, drug stores, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

For any questions related to Fungal Keratitis Treatment Market, Fungal Keratitis Treatment Market Size, Fungal Keratitis Treatment Market Growth, Fungal Keratitis Treatment Market Analysis, Fungal Keratitis Treatment Market Report, Fungal Keratitis Treatment Market Share, Fungal Keratitis Treatment Market Trends, Fungal Keratitis Treatment Market Forecast, Fungal Keratitis Treatment Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.

ページTOPに戻る

Table of Contents

Table of Contents

1. Executive Summary




2. Global Fungal Keratitis Treatment Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)


3.3: Global Fungal Keratitis Treatment Market by Route of Administration
3.3.1: Oral
3.3.2: Injection
3.3.3: Topical







3.4: Global Fungal Keratitis Treatment Market by Distribution Channel
3.4.1: Hospitals
3.4.2: Drug Stores
3.4.3: Others



















4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Fungal Keratitis Treatment Market by Region
4.2.1: North American Fungal Keratitis Treatment Market by Route of Administration: Oral, Injection, and Topical
4.2.2: North American Fungal Keratitis Treatment Market by Distribution Channel: Hospitals, Drug Stores, and Others



4.3: European Fungal Keratitis Treatment Market
4.3.1: European Fungal Keratitis Treatment Market by Route of Administration: Oral, Injection, and Topical
4.3.2: European Fungal Keratitis Treatment Market by Distribution Channel: Hospitals, Drug Stores, and Others



4.4: APAC Fungal Keratitis Treatment Market
4.4.1: APAC Fungal Keratitis Treatment Market by Route of Administration: Oral, Injection, and Topical
4.4.2: APAC Fungal Keratitis Treatment Market by Distribution Channel: Hospitals, Drug Stores, and Others



4.5: ROW Fungal Keratitis Treatment Market
4.5.1: ROW Fungal Keratitis Treatment Market by Route of Administration: Oral, Injection, and Topical
4.5.2: ROW Fungal Keratitis Treatment Market by Distribution Channel: Hospitals, Drug Stores, and Others



5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Fungal Keratitis Treatment Market by Route of Administration
6.1.2: Growth Opportunities for the Global Fungal Keratitis Treatment Market by Distribution Channel
6.1.3: Growth Opportunities for the Global Fungal Keratitis Treatment Market by Region
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Fungal Keratitis Treatment Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Fungal Keratitis Treatment Market


7. Company Profiles of Leading Players
7.1: Merck & Co
7.2: Bausch Health
7.3: Gilead Biosciences
7.4: Pfizer
7.5: Glenmark Pharmaceuticals